Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 01-Jul-24 5:00 PM View:  | Gain Therapeutics, Inc. (GANX) | 01-Jul-24 | Private Purchase | 17,000 | $1.22 | $20,670.00 | 6% 287.46K to 304.46K | |
| 22-Sep-23 4:34 PM View: | Gain Therapeutics, Inc. (GANX) | 20-Sep-23 | Option Exercise | 54,900 | -- | -- | 24% 232.56K to 287.46K | |
| 27-May-22 4:10 PM View: | Gain Therapeutics, Inc. (GANX) | 25-May-22 | Private Purchase | 2,482 | $2.58 | $6,403.56 | 1% 230.08K to 232.56K | |
| 23-May-22 4:41 PM View: | Gain Therapeutics, Inc. (GANX) | 20-May-22 | Purchase | 9,256 | $2.83 | $26,194.50 | 4% 220.82K to 230.08K | |
| 23-May-22 4:41 PM View: | Gain Therapeutics, Inc. (GANX) | 19-May-22 | Private Purchase | 4,000 | $2.71 | $10,840.00 | 2% 216.82K to 220.82K | |
| 07-Mar-22 7:13 PM View: | Ohr Pharmaceutical, Inc. (NBSE) | 04-Mar-22 | Purchase | 1,000 | $1.62 | $1,620.00 | 1% 71.71K to 72.71K | |
| 07-Mar-22 7:13 PM View: | Ohr Pharmaceutical, Inc. (NBSE) | 03-Mar-22 | Purchase | 1,300 | $1.72 | $2,236.00 | 2% 70.41K to 71.71K | |
| 07-Mar-22 7:13 PM View: | Ohr Pharmaceutical, Inc. (NBSE) | 01-Mar-22 | Private Purchase | 1,580 | $1.58 | $2,496.40 | 2% 68.83K to 70.41K | |
| 17-Aug-21 9:03 PM View: | Gain Therapeutics, Inc. (GANX) | 16-Aug-21 | Option Exercise | 4,922 | $7.87 | $38,716.50 | 2% 211.9K to 216.82K | |
| 27-Apr-21 4:03 PM View: | Ohr Pharmaceutical, Inc. (NBSE) | 26-Apr-21 | Private Purchase | 5,000 | $5.00 | $25,000.00 | 8% 63.83K to 68.83K | |
| 04-May-20 9:56 AM View: | Ohr Pharmaceutical, Inc. (NBSE) | 30-Apr-20 | Private Purchase | 2,500 | $6.00 | $15,000.00 | 5% 52.99K to 55.49K | |
| 04-May-20 9:56 AM View: | Ohr Pharmaceutical, Inc. (NBSE) | 30-Apr-20 | Private Purchase | 8,333 | $6.00 | $49,998.00 | 15% 55.49K to 63.83K | |
| 03-Mar-20 7:10 PM View: | Adma Biologics, Inc. (ADMA) | 28-Feb-20 | Grant | 7,500 | -- | -- | 21% 36.53K to 44.03K | |
| 16-Jul-19 8:35 PM View: | Ohr Pharmaceutical, Inc. (NBSE) | 12-Jul-19 | Grant | 25,247 | -- | -- | 100% 0 to 25.25K | |
| 11-Jun-18 7:08 AM View: | Adma Biologics, Inc. (ADMA) | 08-Jun-18 | Purchase | 5,230 | $4.78 | $24,999.40 | 17% 31.3K to 36.53K | |
| 13-Nov-17 1:51 PM View: | Adma Biologics, Inc. (ADMA) | 09-Nov-17 | Purchase | 25,000 | $2.15 | $53,750.00 | 397% 6.3K to 31.3K | |
| 17-Jul-17 5:12 PM View: | Adma Biologics, Inc. (ADMA) | 13-Jul-17 | Option Exercise | 2,800 | $2.68 | $7,504.00 | 80% 3.5K to 6.3K | |
| 23-Nov-16 4:46 PM View: | PharmAthene, Inc. (ALT) | 22-Nov-16 | Option Exercise | 483,733 | $1.85 | $895,213.00 | 114% 424.32K to 908.05K | |
| 30-Sep-16 4:33 PM View: | PharmAthene, Inc. (ALT) | 28-Sep-16 | Option Exercise | 237,500 | $1.45 | $343,625.00 | 127% 186.82K to 424.32K | |
| 15-Apr-16 7:53 PM View: | PharmAthene, Inc. (ALT) | 13-Apr-16 | Option Exercise | 329,354 | $1.19 | $392,240.00 | 176% 186.82K to 516.18K | |
| 15-Apr-16 7:53 PM View: | PharmAthene, Inc. (ALT) | 13-Apr-16 | Market Option Sale (Planned) | 329,354 | $2.20 | $724,579.00 | (64%) 516.18K to 186.82K | 126% |
| 11-Apr-16 6:18 PM View: | PharmAthene, Inc. (ALT) | 08-Apr-16 | Option Exercise | 6,400 | $1.76 | $11,264.00 | 3% 186.82K to 193.22K | (2%) |
| 11-Apr-16 6:18 PM View: | PharmAthene, Inc. (ALT) | 08-Apr-16 | Market Option Sale (Planned) | 6,400 | $2.20 | $14,080.00 | (3%) 193.22K to 186.82K | 126% |
| 11-Apr-16 6:18 PM View: | PharmAthene, Inc. (ALT) | 07-Apr-16 | Option Exercise | 5,367 | $1.76 | $9,445.92 | 3% 186.82K to 192.19K | (2%) |
| 11-Apr-16 6:18 PM View: | PharmAthene, Inc. (ALT) | 07-Apr-16 | Market Option Sale (Planned) | 5,367 | $2.20 | $11,807.40 | (3%) 192.19K to 186.82K | 126% |
| 17-Mar-15 8:43 PM View: | Adma Biologics, Inc. (ADMA) | 13-Mar-15 | Purchase | 3,500 | $7.88 | $27,570.00 | 100% 0 to 3.5K | |
| 08-Mar-12 5:33 PM View: | PharmAthene, Inc. (ALT) | 07-Mar-12 | Payment of Exercise | 22,500 | -- | -- | (11%) 209.32K to 186.82K | |
| 13-Dec-11 5:29 PM View: | PharmAthene, Inc. (ALT) | 07-Dec-11 | Grant | 75,000 | -- | -- | 56% 134.32K to 209.32K | |
| 14-Nov-11 6:51 AM View: | PharmAthene, Inc. (ALT) | 10-Nov-11 | Market Purchase | 10,000 | $1.50 | $15,024.80 | 8% 124.32K to 134.32K | (138%) |
| 04-Oct-11 7:33 PM View: | PharmAthene, Inc. (ALT) | 30-Sep-11 | Grant | 25,000 | -- | -- | 25% 99.32K to 124.32K | |
| 25-Jan-11 5:00 PM View: | PharmAthene, Inc. (ALT) | 21-Jan-11 | Payment of Exercise | 3,057 | $3.42 | $10,454.90 | (3%) 112.88K to 109.82K | 118% |
| 28-Dec-10 6:27 PM View: | PharmAthene, Inc. (ALT) | 23-Dec-10 | Grant | 35,000 | -- | -- | 45% 77.88K to 112.88K | |
| 05-Nov-10 8:32 PM View: | PharmAthene, Inc. (ALT) | 03-Nov-10 | Conversion | 7,306 | $2.54 | $18,569.70 | 10% 70.57K to 77.88K | |
| 21-Jun-10 8:22 PM View: | PharmAthene, Inc. (ALT) | 17-Jun-10 | Market Purchase | 10,000 | $1.58 | $15,767.00 | 17% 60.57K to 70.57K | (138%) |
| 12-May-11 6:55 PM View: | PharmAthene, Inc. (ALT) | 23-Mar-10 | Payment of Exercise | 10,500 | $3.40 | $35,700.00 | (10%) 109.82K to 99.32K | |
| 23-Jan-09 4:26 PM View: | PharmAthene, Inc. (ALT) | 21-Jan-09 | Grant | 30,573 | -- | -- | 102% 30.0K to 60.57K | |
| 04-Oct-07 6:11 PM View: | PharmAthene, Inc. (ALT) | 02-Oct-07 | Grant | 30,000 | -- | -- | 100% 0 to 30.0K |